Methods for preventing or treating certain disorders by inhibiting binding of il-4 and/or il-13 to their respective receptors
US-2023021168-A1 · Jan 19, 2023 · US
This page is not indexed by search engines while we improve data quality.
Hohlbaum Andreas patents
Hohlbaum Andreas is listed as an inventor on 28 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Hohlbaum Andreas |
| Total patents | 28 |
| First publication | Oct 6, 2015 |
| Latest publication | Jan 19, 2023 |
Notable patents
Publications ranked by popularity score, then publication date.
Methods for preventing or treating certain disorders by inhibiting binding of IL-4 and/or IL-13 to their respective receptors
US-11382951-B2 · Jul 12, 2022 · US
Tear lipocalin muteins binding il-4 r alpha
US-2021196788-A1 · Jul 1, 2021 · US
Methods for preventing or treating certain disorders by inhibiting binding of il-4 and/or il-13 to their respective receptors
US-2021145934-A1 · May 20, 2021 · US
Tear lipocalin muteins binding IL-4 r alpha
US-10898545-B2 · Jan 26, 2021 · US
Methods for preventing or treating certain disorders by inhibiting binding of IL-4 and/or IL-13 to their respective receptors
US-10857202-B2 · Dec 8, 2020 · US
Methods for preventing or treating certain disorders by inhibiting binding of il-4 and/or il-13 to their respective receptors
US-2020009223-A1 · Jan 9, 2020 · US
Methods for preventing or treating certain disorders by inhibiting binding of IL-4 and/or IL-13 to their respective receptors
US-10398754-B2 · Sep 3, 2019 · US
Tear lipocalin muteins binding il-4 r alpha
US-2019240289-A1 · Aug 8, 2019 · US
Tear lipocalin muteins binding IL-4 R alpha
US-10232014-B2 · Mar 19, 2019 · US
Recent patents
Latest publications not already listed above.
Methods for preventing or treating certain disorders by inhibiting binding of il-4 and/or il-13 to their respective receptors
US-2019030121-A1 · Jan 31, 2019 · US
Muteins of tear lipocalin and methods for obtaining the same
US-2019015477-A1 · Jan 17, 2019 · US
Methods for preventing or treating disorders by increasing bioavailability of iron and related pharmaceutical formulation
US-2018311311-A1 · Nov 1, 2018 · US
Muteins of tear lipocalin and methods for obtaining the same
US-10046027-B2 · Aug 14, 2018 · US
Methods for preventing or treating certain disorders by inhibiting binding of IL-4 and/or IL-13 to their respective receptors
US-10016483-B2 · Jul 10, 2018 · US
Methods for preventing or treating disorders by increasing bioavailability of iron and related pharmaceutical formulation
US-9950034-B2 · Apr 24, 2018 · US
Human neutrophil gelatinase-associated lipocalin (hngal) muteins that bind hepcidin and nucleic acid encoding such
US-2017369542-A1 · Dec 28, 2017 · US
Tear lipocalin muteins binding il-4 r alpha
US-2017340703-A1 · Nov 30, 2017 · US
Muteins with tear lipocalin having affinity to human c-met receptor tyrosine kinase and methods for obtaining the same
US-9751920-B2 · Sep 5, 2017 · US
Methods for preventing or treating disorders by increasing bioavailability of iron and related pharmaceutical formulation
US-2017224770-A1 · Aug 10, 2017 · US
Tear lipocalin muteins binding IL-4 R alpha
US-9687524-B2 · Jun 27, 2017 · US
Novel binding proteins for pcsk9
US-2017173112-A1 · Jun 22, 2017 · US
Methods for preventing or treating certain disorders by inhibiting binding of il-4 and/or il-13 to their respective receptors
US-2017112900-A1 · Apr 27, 2017 · US
Methods for preventing or treating disorders by increasing bioavailability of iron and related pharmaceutical formulation
US-9610356-B2 · Apr 4, 2017 · US
Nucleic acid molecules encoding muteins of human tear lipocalin which bind PCSK9
US-9598476-B2 · Mar 21, 2017 · US
Methods for preventing or treating certain disorders by inhibiting binding of IL-4 and/or IL-13 to their respective receptors
US-9572863-B2 · Feb 21, 2017 · US
Novel binding proteins for pcsk9
US-2016024161-A1 · Jan 28, 2016 · US
Human tear lipocalins which bind PCSK9 and methods of use thereof
US-9150629-B2 · Oct 6, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Pieris Pharmaceuticals Gmbh | 23 |
| Astrazeneca Ab | 12 |
| Daiichi Sankyo Co Ltd | 5 |
| Pieris Pharmaceuticlas GmbH | 1 |
| Pieris Ag | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P43/00 | 27 |
| A61K38/1709 | 26 |
| A61P35/00 | 23 |
| C07K14/47 | 18 |
| A61P29/00 | 17 |